Business and News Update October 2011
Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
- ERT (Philadelphia, PA) has appointed Linda Deal to lead ERT's Health Outcomes Research initiatives.
- inVentiv Health (Burlington, MA) has appointed Mark Dmytruk as President of inVentiv Health Patient Outcomes.
- With more than 20 years experience in the laboratory manufacturing and distribution services, construction, and public accounting industries, Christopher O'Connell has joined Marken (London, UK) as the company's Chief Financial Officer. Marken has also appointed Frank J. Wright as the Interim President of the Clinical Trials Distribution Business Unit.
- BioConvergence (Bloomington, IN) has appointed Kathy Eddy as its Chief Financial Officer, where she will oversee the finance, human resources, and information technology departments.
- The CRS Group (Andernach , Germany) has been joined by two recent arrivals. Berthold Lausecker, PhD, became CRS's new Director of Bioanalytics this Spring and Wolfgang Höffer, MD, joined as Director, Corporate Development.
Linda Deal
Alliances
- Worldwide Clinical Trials (King of Prussia, PA) and Thomas Jefferson University's School of Population (Philadelphia, PA) have entered into an alliance to provide pharmaceutical and biotechnology clients with a broad range of outcomes research services including comparative effectiveness, burden of illness, and quality of life studies.
- INC Research (Raleigh, NC) and Debiopharm Group (Lausanne, Switzerland) announced a strategic partnership where Debiopharm will entrust INC Research with the management of a clinical study linked to an important project in Debiopharm's pipeline.
- Medidata Solutions (New York, NY) announced that specialty contract research organization QCTR (Stirling, UK) has selected Medidata CTMS, including its investigator site payment module, to manage the operations of all their clinical studies.
Mark Dmytruk
Awards
- Rabinder Buttar, PhD, CEO and President of Global CRO, ClinTec International (Glasgow, UK) attended a reception at Buckingham Palace to celebrate winning the Queens Award for Enterprise.
- Martin Mackay, PhD, President of Research and Development with AstraZeneca (Wilmington, DE), has been awarded an honorary Doctor of Science from the University of Brighton in recognition of his "significant achievements in the pharmaceutical industry over the past 30 years."
- Vetter (Ravensburg, Germany) received certification for its integrated management system for environmental, health, and safety. The company earned ISO 14001 certification for its environmental management system and BS OHSAS 18001 certification for its occupational health and safety management system.
Christopher O'Connell
Company News
- ClearTrial (Chicago, IL) announced that results of a new survey of life sciences professionals charged with forecasting and budgeting clinical studies at small, mid-sized, and top 20 biopharmaceutical and medical device companies show that the life sciences industry continues to experience difficulty accurately predicting spending for clinical development. The survey is available for download at http://info.cleartrial.com/budgeting-survey.html.
- DecisionView (San Francisco, CA) announced the release of StudyOptimizer 4.3, the latest version of the company's flagship solution for patient enrollment planning, tracking, and forecasting.
Martin Mackay, PhD
New Facilities
- PRA (Raleigh, NC) has created a legal entity in Bulgaria and opened a new office in Bucharest, Romania to further strengthen coverage of the Balkan region's burgeoning markets. The Bucharest office will also support projects in the neighboring Republic of Moldova.
- Gen-Probe Life Sciences (San Diego, CA) has completed the consolidation of its Molecular Genetic Services business at its newly expanded facilities in Manchester.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
